Clinical Trials Directory

Trials / Unknown

UnknownNCT01882296

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

A Block-randomized, Open-Label, Multiple Oral Dosing, Phase I Study to Explore Comparability of the Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

Primary object: Evaluate Pharmacodynamic property and safety administered S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in healthy male subjects Secondary object : Evaluate Dose-response of S-pantoprazole and pantoprazole and compare each dose-response

Conditions

Interventions

TypeNameDescription
DRUGAGSPT_10AGSPT 10mg for 7days administration
DRUGAGSPT_20AGSPT 20mg for 7days administration
DRUGAGSPT_40AGSPT 20mg x 2tablet for 7days administration
DRUGPantoprazole_20Pantoprazole 20mg for 7days administration
DRUGPantoprazole_40Pantoprazole 40mg for 7days administration

Timeline

Primary completion
2013-09-01
First posted
2013-06-20
Last updated
2013-06-20

Source: ClinicalTrials.gov record NCT01882296. Inclusion in this directory is not an endorsement.